181 results on '"Auclerc G"'
Search Results
2. Chemo-immunotherapy of metastatic malignant melanoma The Salpetriere Hospital (SOMPS) experience
3. Neo-Adjuvant chemotherapy in breast cancer Study of 477 evaluable patients with primary breast cancers treated between 1980 and 1992
4. Combined intravenous and intra-arterial chemotherapy using Cisplatin, Fluorouracil, Mitomycin C and Etoposide in the treatment of hepatic metastasis
5. Ten years of breast preserving management in infiltrative breast cancer : results in 412 patients treated by Neo-Adjuvant chemotherapy and radiation therapy with or without hormonotherapy
6. Results of Cisplatin (CDDP)/Etoposide (VP16)/5-FU and alternatively Adriamycin or Mitomycin C (PEFAM) combination in primary resistant breast cancer and in heavily pre-treated metastatic breast cancer
7. Recommandations pour la pratique clinique : Standards, Options : Recommandations 2008 pour la prise en charge des patientes atteintes de tumeurs épithéliales malignes de l’ovaire. Traitement médical de première ligne (rapport abrégé)
8. Étude épidémiologique observationnelle française sur la prise en charge des tumeurs solides en cancérologie privée
9. La formation médicale en cancérologie libérale
10. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
11. Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancer: A Study of 252 Patients
12. Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancers: Study of 143 Patients
13. Long-Term Cost of Combined Radiotherapy and Chemotherapy
14. Experimental and Clinical Activity of a New Anthracycline Derivative: Detorubicin (14-Diethoxyacetoxydaunorubicin)
15. Malignancies Possibly Secondary to Anticancer Therapy
16. Features and prognosis of chemotherapy-treated Hodgkin's disease with initial bone marrow involvement
17. Malignancies Possibly Secondary to Anticancer Therapy
18. Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancer: A Study of 252 Patients
19. Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancers: Study of 143 Patients
20. A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy
21. Influence of geriatric consultation with Comprehensive Geriatric Assessment (CGA) on therapeutic decision in elderly cancer patients
22. Coexpression of EGFR, pEGFR, VEGF, pVEGF, PTEN, pAKT, and p21 in colorectal cancer patients can have IHC variability between metastases and primary tumours and for EGFR-targeted therapies, p21 and VEGF appear reliably as predictive factors of response
23. Presence of VEGF-R3 in the serum of metastatic malignant melanoma patients: Relationship with clinicobiological parameters
24. Relationship of soluble VEGF-C and VEGF-D with clinicopathological parameters in metastatic malignant melanoma patients treated by biochemotherapy
25. �tude �pid�miologique observationnelle fran�aise sur la prise en charge des tumeurs solides en canc�rologie priv�e
26. Clinical significance of serum epidermal growth factor receptor, vascular endothelial growth factor and soluble interleukin-6 in advanced melanoma patients
27. Detecci?n precoz y prevenci?n en oncolog?a
28. Epidemiolog?a y c?ncer
29. Systemic treatment of metastatic malignant melanoma
30. 15 An update of chemotherapy including fotemustine in the treatment of disseminated malignant melanoma (DMM)
31. Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma
32. 955 A phase I study of concomitant CPT-11 (C) and 5FU (F) combination: Preliminary results
33. Tamoxifen (TMX), cisplatinum (CDDP), interleukin 2 (IL2) and alpha-interferon (αlFN) combination in the treatment of metastatic malignant melanoma (MMM)
34. Results of two large randomized prospective studies of nonspecific adjuvant immunotherapy of thin malignant melanoma (MM)
35. Cistplatinum (CDDP) - interleukin 2 (IL2) -Alpha-interferon (oc-IFN) chemoimmunotherapy of metastatic malignant melanoma
36. Active outpatient, three drugs Fotemustine (FTMU), Dacarbarzine (DTIC), Vindestine (VDS)) combination in advanced malignant melanoma (MM)
37. Metastatic malignant melanoma (MMM)
38. Chemoimmunotherapy of metastatic malignant melanoma The Salpétrière Hospital (SOMPS) experiences
39. Interleukin2-alpha-interferon combined with cis-platyl therapy in metastatic malignant melanoma (MMM) patients: Results of two consecutive trials
40. Nonsurgical Approach in Stage I and Stage II Breast Cancer
41. Fotemustine (S 10036) in the Intra-Arterial Treatment of Liver Metastasis from Malignant Melanoma
42. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer.
43. Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB).
44. Prognostic value of lymphograms in chronic lymphatic leukemia.
45. Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
46. Post-therapeutic acute leukemia.
47. Evaluation of 216 four-year survivors of acute leukemia.
48. Long-Term Cost of Combined Radiotherapy and Chemotherapy
49. Features and prognosis of chemotherapy-treated Hodgkin's disease with initial bone marrow involvement
50. Analysis of a co-operative study of adjuvant chemotherapy in breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.